The latest myeloma news
Metabolic response behind reduced cancer cell growth
Researchers from Uppsala University in Sweden show in a new study that inhibition of the…
Browsing: Myeloma
Designer DNA therapeutic wipes out cancer stem cells, treats multiple myeloma in mice
Many patients with multiple myeloma, a type of blood cancer, eventually develop resistance to one…
ASTRO 2020: Study supports use of radiation before CAR therapy for multiple myeloma
Administering radiation therapy to multiple myeloma patients waiting for CAR T cells to be manufactured…
Potential cause of immunotherapy-related neurotoxicity
New research has uncovered the previously unknown presence of CD19 — a B cell molecule…
Novel immune-oncology approach for potential cancer treatment
A research collaboration between Monash University and Lava Therapeutics details a novel immune-oncology approach for…
FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma
On August 20, 2020, the Food and Drug Administration approved carfilzomib and daratumumab in combination…
UV-detecting stickers warn young footballers to apply sunscreen
The simple act of putting a UV-detecting sticker on sun-exposed skin while playing outdoor sport…
New multiple myeloma therapy shows promise in preclinical study
A new alpha-radioimmunotherapy, 212Pb-anti-CD38, has proven effective in preventing tumour growth and increasing survival in…
FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma
The Food and Drug Administration (FDA) approved belantamab mafodotin-blmf for adult patients with relapsed or…
Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed
This content is password-protected. To view it, please enter the password below. Password: